{"transactions":[{"id":2724,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":3932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":3932},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2723,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":2557,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2558},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2722,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024."}],"balance_after":4725,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2362},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2721,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":7931,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2644},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2720,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026."}],"balance_after":14600,"derivative":{"exercise_price":79.28,"expiration_date":"2036-08-31","underlying":"Class A Ordinary Share","underlying_shares":14600},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2719,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026."}],"balance_after":3650,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2718,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":80.3,"value":369380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":29062,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2717,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":5531,"price":79.28,"value":438497.68,"ownership":{"direct":true},"balance_after":33662,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2716,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2644,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":39193,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2715,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":36549,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2714,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2558,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":34187,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2713,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":3932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":31629,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":2712,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-09-03T20:40:17.000Z","date":"2026-07-15","kind":"grant","planned":true,"acquired":true,"shares":279,"price":33.5,"value":9346.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2026 to July 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e)."}],"balance_after":27697,"source":{"system":"sec-edgar","filing":"0001464583-26-000008","document":"form4-09032026_080913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000008/form4-09032026_080913.xml","form_type":"4"}},{"id":809636,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-04-13T20:35:46.000Z","date":"2026-04-09","kind":"sale","planned":true,"acquired":false,"shares":6625,"price":46.69,"value":309321.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":27418,"source":{"system":"sec-edgar","filing":"0001464583-26-000006","document":"form4-04132026_080442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000006/form4-04132026_080442.xml","form_type":"4"}},{"id":812562,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-04-08T20:38:25.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":false,"shares":3932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":3932},"source":{"system":"sec-edgar","filing":"0001464583-26-000004","document":"form4-04082026_080417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000004/form4-04082026_080417.xml","form_type":"4"}},{"id":812561,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:38:25.000Z","date":"2026-04-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1666,"price":48.94,"value":81534.04,"ownership":{"direct":true},"balance_after":34043,"source":{"system":"sec-edgar","filing":"0001464583-26-000004","document":"form4-04082026_080417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000004/form4-04082026_080417.xml","form_type":"4"}},{"id":812560,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-04-08T20:38:25.000Z","date":"2026-04-07","kind":"exercise","planned":false,"acquired":true,"shares":3932,"price":1,"value":3932.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":35709,"source":{"system":"sec-edgar","filing":"0001464583-26-000004","document":"form4-04082026_080417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000004/form4-04082026_080417.xml","form_type":"4"}},{"id":816504,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":2644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025."}],"balance_after":7931,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2644},"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816503,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":2362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024."}],"balance_after":4725,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2362},"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816502,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":2558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023."}],"balance_after":2557,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2558},"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816501,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Performance Share Unit","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":7300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":7300,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":73000},"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816500,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter."}],"balance_after":3650,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816499,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026."}],"balance_after":14600,"derivative":{"exercise_price":48.13,"expiration_date":"2036-03-31","underlying":"Class A Ordinary Share","underlying_shares":14600},"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816498,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3205,"price":48.13,"value":154256.65,"ownership":{"direct":true},"balance_after":31777,"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816497,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-04-03T20:34:34.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":7564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":34982,"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":816496,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2026-04-03T20:34:34.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":372,"price":24.16,"value":8987.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase  period of July 16, 2025 to January 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e)."}],"balance_after":27418,"source":{"system":"sec-edgar","filing":"0001464583-26-000002","document":"form4-04032026_080430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458326000002/form4-04032026_080430.xml","form_type":"4"}},{"id":1014726,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":12787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.76,"expiration_date":"2033-03-31","underlying":"Class A Ordinary Share","underlying_shares":12787},"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014725,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":9831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":11.97,"expiration_date":"2032-08-31","underlying":"Class A Ordinary Share","underlying_shares":9831},"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014724,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":9831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":11.1,"expiration_date":"2032-04-06","underlying":"Class A Ordinary Share","underlying_shares":9831},"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014723,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":6195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.97,"expiration_date":"2031-09-01","underlying":"Class A Ordinary Share","underlying_shares":6195},"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014722,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":false,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.5,"expiration_date":"2030-09-09","underlying":"Class A Ordinary Share","underlying_shares":791},"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014721,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":13235,"price":39.31,"value":520267.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.145 and $39.57. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":27046,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014720,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":37255,"price":38.72,"value":1442513.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.14 and $39.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":40281,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014719,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":12787,"price":10.76,"value":137588.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":77536,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014718,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":9831,"price":11.97,"value":117677.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":64749,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014717,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":9831,"price":11.1,"value":109124.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":54918,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014716,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":6195,"price":12.97,"value":80349.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":45087,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1014715,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-22T21:06:50.000Z","date":"2025-10-20","kind":"exercise","planned":true,"acquired":true,"shares":791,"price":15.5,"value":12260.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025."}],"balance_after":38892,"source":{"system":"sec-edgar","filing":"0001464583-25-000005","document":"form4-10222025_091045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/form4-10222025_091045.xml","form_type":"4"}},{"id":1021534,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-10-08T20:58:18.000Z","date":"2025-10-04","kind":"exercise","planned":false,"acquired":false,"shares":175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":175},"source":{"system":"sec-edgar","filing":"0001464583-25-000003","document":"form4-10082025_081015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000003/form4-10082025_081015.xml","form_type":"4"}},{"id":1021533,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-08T20:58:18.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":85,"price":38.49,"value":3271.65,"ownership":{"direct":true},"balance_after":38101,"source":{"system":"sec-edgar","filing":"0001464583-25-000003","document":"form4-10082025_081015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000003/form4-10082025_081015.xml","form_type":"4"}},{"id":1021532,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-10-08T20:58:18.000Z","date":"2025-10-04","kind":"exercise","planned":false,"acquired":true,"shares":175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":38186,"source":{"system":"sec-edgar","filing":"0001464583-25-000003","document":"form4-10082025_081015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000146458325000003/form4-10082025_081015.xml","form_type":"4"}},{"id":1049808,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option is fully vested and Exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.92,"expiration_date":"2029-03-03","underlying":"Class A Ordinary Share","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049807,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":false,"shares":774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":774},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049806,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"exercise","planned":true,"acquired":false,"shares":3933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022."}],"balance_after":3932,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":3933},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049805,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023."}],"balance_after":5115,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2557},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049804,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"exercise","planned":true,"acquired":false,"shares":2363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024."}],"balance_after":7087,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":2363},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049803,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"grant","planned":true,"acquired":true,"shares":21150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025."}],"balance_after":21150,"derivative":{"exercise_price":33.49,"expiration_date":"2035-08-31","underlying":"Class A Ordinary Share","underlying_shares":21150},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049802,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"grant","planned":true,"acquired":true,"shares":10575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025."}],"balance_after":10575,"derivative":{"underlying":"Class A Ordinary  Share","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049801,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":34.84,"value":383240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $34.80 and $35.005. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":38011,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049800,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":17.92,"value":197120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":49011,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049799,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":375,"price":34.28,"value":12855.0,"ownership":{"direct":true},"balance_after":38011,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049798,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-02","kind":"exercise","planned":true,"acquired":true,"shares":774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":38386,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049797,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":4282,"price":33.49,"value":143404.18,"ownership":{"direct":true},"balance_after":37612,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049796,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"exercise","planned":true,"acquired":true,"shares":3933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":41894,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049795,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2557,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":37961,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1049794,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-09-03T20:56:19.000Z","date":"2025-09-01","kind":"exercise","planned":true,"acquired":true,"shares":2363,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":35404,"source":{"system":"sec-edgar","filing":"0001415889-25-023564","document":"form4-09032025_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925023564/form4-09032025_080915.xml","form_type":"4"}},{"id":1073156,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-08-06T20:30:07.000Z","date":"2025-08-04","kind":"exercise","planned":true,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 13, 2020."}],"balance_after":0,"derivative":{"exercise_price":15.52,"expiration_date":"2030-03-12","underlying":"Class A Ordinary Share","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001415889-25-021177","document":"form4-08062025_040801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021177/form4-08062025_040801.xml","form_type":"4"}},{"id":1073155,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-08-06T20:30:07.000Z","date":"2025-08-04","kind":"sale","planned":true,"acquired":false,"shares":17000,"price":32.35,"value":549950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.01 and $32.895. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":33041,"source":{"system":"sec-edgar","filing":"0001415889-25-021177","document":"form4-08062025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021177/form4-08062025_040801.xml","form_type":"4"}},{"id":1073154,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-08-06T20:30:07.000Z","date":"2025-08-04","kind":"exercise","planned":true,"acquired":true,"shares":17000,"price":15.52,"value":263840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":50041,"source":{"system":"sec-edgar","filing":"0001415889-25-021177","document":"form4-08062025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021177/form4-08062025_040801.xml","form_type":"4"}},{"id":1073153,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-08-06T20:30:07.000Z","date":"2025-07-15","kind":"grant","planned":true,"acquired":true,"shares":495,"price":15.63,"value":7736.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2025 to July 15, 2025. The acquisition of these shares was exempt pursuant to Rule 16b-3(e)."}],"balance_after":33041,"source":{"system":"sec-edgar","filing":"0001415889-25-021177","document":"form4-08062025_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021177/form4-08062025_040801.xml","form_type":"4"}},{"id":1121395,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-06-05T20:50:16.000Z","date":"2025-06-03","kind":"exercise","planned":true,"acquired":false,"shares":15211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":791,"derivative":{"exercise_price":15.5,"expiration_date":"2030-09-09","underlying":"Class A Ordinary Share","underlying_shares":15211},"source":{"system":"sec-edgar","filing":"0001415889-25-015782","document":"form4-06052025_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015782/form4-06052025_080606.xml","form_type":"4"}},{"id":1121394,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-06-05T20:50:16.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":15211,"price":28.75,"value":437316.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $28.75 and $28.755. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":32546,"source":{"system":"sec-edgar","filing":"0001415889-25-015782","document":"form4-06052025_080606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015782/form4-06052025_080606.xml","form_type":"4"}},{"id":1121393,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-06-05T20:50:16.000Z","date":"2025-06-03","kind":"exercise","planned":true,"acquired":true,"shares":15211,"price":15.5,"value":235770.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":47757,"source":{"system":"sec-edgar","filing":"0001415889-25-015782","document":"form4-06052025_080606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015782/form4-06052025_080606.xml","form_type":"4"}},{"id":1153757,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":false,"shares":14420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022."}],"balance_after":17040,"derivative":{"exercise_price":11.97,"expiration_date":"2032-08-31","underlying":"Class A Ordinary Share","underlying_shares":14420},"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1153756,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":false,"shares":2998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":16002,"derivative":{"exercise_price":15.5,"underlying":"Class A Ordinary Share","underlying_shares":2998},"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1153755,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":false,"shares":229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":8.83,"underlying":"Class A Ordinary Share","underlying_shares":229},"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1153754,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"sale","planned":true,"acquired":false,"shares":17647,"price":26.69,"value":470998.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":32546,"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1153753,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":true,"shares":14420,"price":11.97,"value":172607.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":50193,"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1153752,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":true,"shares":2998,"price":15.5,"value":46469.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":35773,"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1153751,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-05-09T20:59:48.000Z","date":"2025-05-07","kind":"exercise","planned":true,"acquired":true,"shares":229,"price":8.83,"value":2022.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":32775,"source":{"system":"sec-edgar","filing":"0001415889-25-012532","document":"form4-05092025_080544.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925012532/form4-05092025_080544.xml","form_type":"4"}},{"id":1159327,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Performance Share Option","published_at":"2025-05-05T20:52:19.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":5456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Performance Share Options shall vest and become exercisable, if at all, upon the approval by the FDA of the commercial sale and marketing in the United States of KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."}],"balance_after":5456,"derivative":{"exercise_price":27.74,"expiration_date":"2035-04-30","underlying":"Class A Ordinary Share","underlying_shares":5456},"source":{"system":"sec-edgar","filing":"0001415889-25-011985","document":"form4-05052025_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925011985/form4-05052025_080516.xml","form_type":"4"}},{"id":1159326,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Performance Share Option","published_at":"2025-05-05T20:52:19.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":5285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Performance Share Options shall vest and become exercisable, if at all, upon the submission to the FDA of a biologics license application for KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, with certain exceptions."}],"balance_after":5285,"derivative":{"exercise_price":27.74,"expiration_date":"2035-04-30","underlying":"Class A Ordinary Share","underlying_shares":5285},"source":{"system":"sec-edgar","filing":"0001415889-25-011985","document":"form4-05052025_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925011985/form4-05052025_080516.xml","form_type":"4"}},{"id":1159325,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Performance Share Unit","published_at":"2025-05-05T20:52:19.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":3433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Share Unit (PSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer, based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee."},{"field":"shares","element":"transactionShares","label":"F2","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The PSUs shall vest, if at all, upon the approval by the FDA of the commercial sale and marketing in the United States of KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The PSUs shall vest, if at all, upon the approval by the FDA of the commercial sale and marketing in the United States of KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment with the Company, subject to certain exceptions."}],"balance_after":3433,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":3433},"source":{"system":"sec-edgar","filing":"0001415889-25-011985","document":"form4-05052025_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925011985/form4-05052025_080516.xml","form_type":"4"}},{"id":1159324,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Performance Share Unit","published_at":"2025-05-05T20:52:19.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":3270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Share Unit (PSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer, based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee."},{"field":"shares","element":"transactionShares","label":"F2","text":"The award is subject to an earnout percentage of 100%, 75%, 50% or 0%, depending on the date of performance criteria achievement. This figure represents achievement at the 100% earnout performance achievement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The PSUs shall vest, if at all, upon the submission to the U.S. Food and Drug Administration (the \"FDA\") of a biologics license application for KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment\nwith the Company, subject to certain exceptions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The PSUs shall vest, if at all, upon the submission to the U.S. Food and Drug Administration (the \"FDA\") of a biologics license application for KPL-387 for the treatment of recurrent pericarditis, subject to the Participant's continued employment\nwith the Company, subject to certain exceptions."}],"balance_after":3270,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":3270},"source":{"system":"sec-edgar","filing":"0001415889-25-011985","document":"form4-05052025_080516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925011985/form4-05052025_080516.xml","form_type":"4"}},{"id":1174728,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-04-09T20:41:50.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":false,"shares":3933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022."}],"balance_after":3932,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":3933},"source":{"system":"sec-edgar","filing":"0001415889-25-010476","document":"form4-04092025_080447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925010476/form4-04092025_080447.xml","form_type":"4"}},{"id":1174727,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-04-09T20:41:50.000Z","date":"2025-04-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1666,"price":20.28,"value":33786.48,"ownership":{"direct":true},"balance_after":32546,"source":{"system":"sec-edgar","filing":"0001415889-25-010476","document":"form4-04092025_080447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925010476/form4-04092025_080447.xml","form_type":"4"}},{"id":1174726,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-04-09T20:41:50.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":true,"shares":3933,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":34212,"source":{"system":"sec-edgar","filing":"0001415889-25-010476","document":"form4-04092025_080447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925010476/form4-04092025_080447.xml","form_type":"4"}},{"id":1179685,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":2363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter."}],"balance_after":7087,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2363},"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179684,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":2557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023."}],"balance_after":5115,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":2557},"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179683,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":10575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025."}],"balance_after":10575,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":10575},"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179682,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":21150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2025."}],"balance_after":21150,"derivative":{"exercise_price":21.77,"expiration_date":"2035-03-31","underlying":"Class A Ordinary Share","underlying_shares":21150},"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179681,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1001,"price":21.77,"value":21791.77,"ownership":{"direct":true},"balance_after":30279,"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179680,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1083,"price":21.77,"value":23576.91,"ownership":{"direct":true},"balance_after":31280,"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179679,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":2363,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":32363,"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1179678,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-04-03T20:52:16.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":2557,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001415889-25-009991","document":"form4-04032025_080410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925009991/form4-04032025_080410.xml","form_type":"4"}},{"id":1197161,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2025-03-19T21:51:36.000Z","date":"2025-03-16","kind":"exercise","planned":false,"acquired":false,"shares":774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, March 16, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, March 16, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":774},"source":{"system":"sec-edgar","filing":"0001415889-25-008618","document":"form4-03192025_090332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008618/form4-03192025_090332.xml","form_type":"4"}},{"id":1197160,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-03-19T21:51:36.000Z","date":"2025-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":328,"price":22.61,"value":7416.08,"ownership":{"direct":true},"balance_after":27443,"source":{"system":"sec-edgar","filing":"0001415889-25-008618","document":"form4-03192025_090332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008618/form4-03192025_090332.xml","form_type":"4"}},{"id":1197159,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-03-19T21:51:36.000Z","date":"2025-03-16","kind":"exercise","planned":false,"acquired":true,"shares":774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":27771,"source":{"system":"sec-edgar","filing":"0001415889-25-008618","document":"form4-03192025_090332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008618/form4-03192025_090332.xml","form_type":"4"}},{"id":1197158,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-03-19T21:51:36.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":469,"price":16,"value":7504.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2024 to January 15, 2025. The acquisition of such shares was exempt pursuant to Rule 16b-3(e)."}],"balance_after":26997,"source":{"system":"sec-edgar","filing":"0001415889-25-008618","document":"form4-03192025_090332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008618/form4-03192025_090332.xml","form_type":"4"}},{"id":1205760,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2025-03-14T20:38:25.000Z","date":"2025-03-12","kind":"exercise","planned":true,"acquired":false,"shares":9051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022."}],"balance_after":13763,"derivative":{"exercise_price":11.1,"expiration_date":"2032-04-06","underlying":"Class A Ordinary Share","underlying_shares":9051},"source":{"system":"sec-edgar","filing":"0001415889-25-008117","document":"form4-03142025_080322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008117/form4-03142025_080322.xml","form_type":"4"}},{"id":1205759,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-03-14T20:38:25.000Z","date":"2025-03-12","kind":"sale","planned":true,"acquired":false,"shares":9051,"price":22.45,"value":203194.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.45 and $22.465. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":26528,"source":{"system":"sec-edgar","filing":"0001415889-25-008117","document":"form4-03142025_080322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008117/form4-03142025_080322.xml","form_type":"4"}},{"id":1205758,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2025-03-14T20:38:25.000Z","date":"2025-03-12","kind":"exercise","planned":true,"acquired":true,"shares":9051,"price":11.1,"value":100466.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":35579,"source":{"system":"sec-edgar","filing":"0001415889-25-008117","document":"form4-03142025_080322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925008117/form4-03142025_080322.xml","form_type":"4"}},{"id":1347234,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2024-12-02T21:36:15.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":9,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022."}],"balance_after":22814,"derivative":{"exercise_price":11.1,"expiration_date":"2032-04-06","underlying":"Class A Ordinary Share","underlying_shares":9},"source":{"system":"sec-edgar","filing":"0001415889-24-027993","document":"form4-12022024_091211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924027993/form4-12022024_091211.xml","form_type":"4"}},{"id":1347233,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Share Option","published_at":"2024-12-02T21:36:15.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":false,"shares":8637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022."}],"balance_after":22823,"derivative":{"exercise_price":11.1,"expiration_date":"2032-04-06","underlying":"Class A Ordinary Share","underlying_shares":8637},"source":{"system":"sec-edgar","filing":"0001415889-24-027993","document":"form4-12022024_091211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924027993/form4-12022024_091211.xml","form_type":"4"}},{"id":1347232,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2024-12-02T21:36:15.000Z","date":"2024-11-29","kind":"sale","planned":true,"acquired":false,"shares":9,"price":22.45,"value":202.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":26528,"source":{"system":"sec-edgar","filing":"0001415889-24-027993","document":"form4-12022024_091211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924027993/form4-12022024_091211.xml","form_type":"4"}},{"id":1347231,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2024-12-02T21:36:15.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":9,"price":11.1,"value":99.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":26537,"source":{"system":"sec-edgar","filing":"0001415889-24-027993","document":"form4-12022024_091211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924027993/form4-12022024_091211.xml","form_type":"4"}},{"id":1347230,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2024-12-02T21:36:15.000Z","date":"2024-11-27","kind":"sale","planned":true,"acquired":false,"shares":8637,"price":22.45,"value":193900.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.45 and $22.465. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":26528,"source":{"system":"sec-edgar","filing":"0001415889-24-027993","document":"form4-12022024_091211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924027993/form4-12022024_091211.xml","form_type":"4"}},{"id":1347229,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2024-12-02T21:36:15.000Z","date":"2024-11-27","kind":"exercise","planned":true,"acquired":true,"shares":8637,"price":11.1,"value":95870.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024."}],"balance_after":35165,"source":{"system":"sec-edgar","filing":"0001415889-24-027993","document":"form4-12022024_091211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924027993/form4-12022024_091211.xml","form_type":"4"}},{"id":1389359,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Restricted Share Unit","published_at":"2024-10-08T20:40:31.000Z","date":"2024-10-04","kind":"exercise","planned":false,"acquired":false,"shares":175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021."}],"balance_after":175,"derivative":{"underlying":"Class A Ordinary Share","underlying_shares":175},"source":{"system":"sec-edgar","filing":"0001415889-24-024885","document":"form4-10082024_081027.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924024885/form4-10082024_081027.xml","form_type":"4"}},{"id":1389358,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":1969,"kind":"person","name":"Megna Michael R","position":1,"cik":"0001464583","reported_name":"Megna Michael R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Class A Ordinary Share","published_at":"2024-10-08T20:40:31.000Z","date":"2024-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":82,"price":24.48,"value":2007.36,"ownership":{"direct":true},"balance_after":26528,"source":{"system":"sec-edgar","filing":"0001415889-24-024885","document":"form4-10082024_081027.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924024885/form4-10082024_081027.xml","form_type":"4"}}],"next_cursor":"2024-10-08T20:40:31.000000Z,1389358"}